Semper Paratus corrects trust account amount in proxy; per-share value $10.34 as of Dec 31, 2022

Tevogen Bio Holdings Inc.

Corrects typographical error: trust account per-share value is $10.34 as of Dec 31, 2022, up from $10.20 as of Sep 30, 2022.
Trust account balance approximately $256.35686 million as of record date Dec 31, 2022; prior filings had outdated figures.
EGM for extension vote remains scheduled for Feb 3, 2023; no change to business combination timeline.
If extension fails, liquidation yields $10.34 per share; warrants expire worthless.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.